Want to see SBC full AI Analyst Report?
SBC Stock Chart & Stats
$4.47
$0.07(1.30%)
At close: 4:00 PM EST
$4.47
$0.07(1.30%)
Day’s Range― - ―
52-Week Range$2.78 - $5.75
Previous CloseN/A
Volume6.18K
Average Volume (3M)65.67K
Market Cap
$334.25M
Enterprise Value$193.14M
Total Cash (Recent Filing)$167.31M
Total Debt (Recent Filing)$51.90M
Price to Earnings (P/E)8.3
Beta0.67
Next Earnings
Aug 19, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.39
Shares Outstanding102,846,950
10 Day Avg. Volume48,167
30 Day Avg. Volume65,672
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)1.79
Price to Sales (P/S)2.56
P/FCF Ratio12.15
Enterprise Value/Market Cap0.58
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit1.62
Enterprise Value/Ebitda2.67
Forecast
1Y Price Target
$8.50Price Target Upside90.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.46
Revenue Forecast (FY)$181.04M
Bulls Say, Bears Say
Bulls Say
High Margins And Strong ROESBC’s very high gross and net margins with ~21% TTM ROE reflect durable pricing power and operating efficiency in aesthetic services. These structural profitability characteristics support reinvestment, franchise backing and the ability to sustain returns through industry cycles.
Conservative Balance Sheet With Low LeverageLow leverage gives SBC financial flexibility to fund clinic expansion, execute strategic initiatives, and absorb demand shocks without heavy interest burdens. A conservatively capitalized structure supports long-term stability and capacity for opportunistic investment.
Strong Free Cash Flow GenerationConsistent positive TTM free cash flow and strong FCF growth indicate SBC can internally fund operations and some expansion. High FCF relative to net income supports durable capital allocation, reduces reliance on external financing, and underpins strategic optionality.
Bears Say
Revenue Decline And Margin Compression From Fee ReformAn April 2025 structural franchise-fee change materially reduced reported revenue and margins, producing a sustained hit to top-line take rates. Because this is a structural contract model shift, it can have lasting negative effects on unit economics, growth trajectory and earnings durability.
Uneven Cash Conversion HistorySBC’s cash generation has been inconsistent across periods, with a notably weak operating cash flow year in 2022. Variable cash conversion raises risk that earnings may not reliably translate to spendable cash in downturns, limiting steady funding for capex or distributions.
Insider Secondary Share Sale And Governance SignalA large CEO secondary sale increases public float without benefiting corporate liquidity and can raise governance or alignment questions. Persistent insider monetization may shift ownership dynamics and could pressure management to prioritize near-term liquidity over long-term strategic initiatives.
SBC Medical Group Holdings News
SBC FAQ
What was SBC Medical Group Holdings’s price range in the past 12 months?
SBC Medical Group Holdings lowest stock price was $2.78 and its highest was $5.75 in the past 12 months.
What is SBC Medical Group Holdings’s market cap?
SBC Medical Group Holdings’s market cap is $334.25M.
When is SBC Medical Group Holdings’s upcoming earnings report date?
SBC Medical Group Holdings’s upcoming earnings report date is Aug 19, 2026 which is in 47 days.
How were SBC Medical Group Holdings’s earnings last quarter?
SBC Medical Group Holdings released its earnings results on May 14, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.098 by $0.012.
Is SBC Medical Group Holdings overvalued?
According to Wall Street analysts SBC Medical Group Holdings’s price is currently Undervalued.
Does SBC Medical Group Holdings pay dividends?
SBC Medical Group Holdings does not currently pay dividends.
What is SBC Medical Group Holdings’s EPS estimate?
SBC Medical Group Holdings’s EPS estimate is 0.12.
How many shares outstanding does SBC Medical Group Holdings have?
SBC Medical Group Holdings has 102,846,950 shares outstanding.
What happened to SBC Medical Group Holdings’s price movement after its last earnings report?
SBC Medical Group Holdings reported an EPS of $0.11 in its last earnings report, beating expectations of $0.098. Following the earnings report the stock price went down -7.74%.
Which hedge fund is a major shareholder of SBC Medical Group Holdings?
Currently, no hedge funds are holding shares in SBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SBC Medical Group Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (90.16% Upside)
$8.50 (90.16% Upside)
Hedge Fund Trend
Decreased
By 200.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $10.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.06%
12-Months-Change
Fundamentals
Return on Equity
16.38%
Trailing 12-Months
Asset Growth
36.34%
Trailing 12-Months
Company Description
SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
SBC Company Deck
SBC Earnings Call
Q1 2026
0:00 / 0:00
SBC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$8.50
▲(90.16% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cra International
―
Forrester Research
―
Franklin Covey Company
―
Resources Connection
―
Aeries Technology
―
Ownership Overview
82.36% Insiders
0.49% Mutual Funds
0.03% Other Institutional Investors
16.29% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---








